Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Euro Surveill ; 25(12)2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-32234116

RESUMEN

In response to the outbreak of COVID-19, we set up a team to carry out sampling in the community. This enabled individuals to remain in self-isolation in their own homes and to prevent healthcare settings and services from being overwhelmed by admissions for sampling of suspected cases. There is evidence that this is a cost effective, safe and necessary service to complement COVID-19 testing in hospitals.


Asunto(s)
Técnicas de Laboratorio Clínico , Infecciones por Coronavirus/diagnóstico , Coronavirus/aislamiento & purificación , Brotes de Enfermedades/prevención & control , Tamizaje Masivo/métodos , Neumonía Viral/prevención & control , Enfermedades Asintomáticas , Betacoronavirus , COVID-19 , Prueba de COVID-19 , Servicios de Salud Comunitaria/organización & administración , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Infecciones por Coronavirus/virología , Humanos , Pandemias , Aislamiento de Pacientes , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , Neumonía Viral/virología , Práctica de Salud Pública , Cuarentena , SARS-CoV-2 , Escocia/epidemiología , Factores de Tiempo
3.
Lancet Healthy Longev ; 1(1): e21-e31, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-34173614

RESUMEN

BACKGROUND: COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. METHODS: We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) and deaths (COVID-19-related and non-COVID-19-related), and we analysed data by several variables including type of care home, number of beds, and locality. Outcome measures were timing of outbreaks, number of confirmed cases of COVID-19 in care home residents, care home characteristics associated with the presence of an outbreak, and deaths of residents in both care homes and hospitals. We calculated excess deaths (both COVID-19-related and non-COVID-19-related), which we defined as the sum of deaths over and above the historical average in the same period over the past 5 years. FINDINGS: Between March 10 and Aug 2, 2020, residents at 189 care homes (5843 beds) were tested for COVID-19 when symptomatic. A COVID-19 outbreak was confirmed at 69 (37%) care homes, of which 66 (96%) were care homes for older people. The size of care homes for older people was strongly associated with a COVID-19 outbreak (odds ratio per 20-bed increase 3·35, 95% CI 1·99-5·63). 907 confirmed cases of SARS-CoV-2 infection were recorded during the study period, and 432 COVID-19-related deaths. 229 (25%) COVID-19-related cases and 99 (24%) COVID-related deaths occurred in five (3%) of 189 care homes, and 441 (49%) cases and 207 (50%) deaths were in 13 (7%) care homes. 411 (95%) COVID-19-related deaths occurred in the 69 care homes with a confirmed COVID-19 outbreak, 19 (4%) deaths were in hospital, and two (<1%) were in one of the 120 care homes without a confirmed COVID-19 outbreak. At the 69 care homes with a confirmed COVID-19 outbreak, 74 excess non-COVID-19-related deaths were reported, whereas ten non-COVID-19-related excess deaths were observed in the 120 care homes without a confirmed COVID-19 outbreak. 32 fewer non-COVID-19-related deaths than expected were reported among care home residents in hospital. INTERPRETATION: The effect of COVID-19 on care homes has been substantial but concentrated in care homes with known outbreaks. A key implication from our findings is that, if community incidence of COVID-19 increases again, many care home residents will be susceptible. Shielding care home residents from potential sources of SARS-CoV-2 infection, and ensuring rapid action to minimise outbreak size if infection is introduced, will be important for any second wave. FUNDING: None.


Asunto(s)
COVID-19 , Anciano , Prueba de COVID-19 , Brotes de Enfermedades , Humanos , Casas de Salud , SARS-CoV-2 , Medicina Estatal , Reino Unido
4.
Vaccine ; 37(37): 5614-5624, 2019 09 03.
Artículo en Inglés | MEDLINE | ID: mdl-31402236

RESUMEN

BACKGROUND: In 2018, there was a record incidence of measles and other vaccine-preventable diseases across developed countries. Declining childhood immunisation uptake in southeast Scotland-an area with a large, highly mobile, and socioeconomically diverse population-threatens regional herd immunity and warrants investigation of suboptimal coverage. As deprivation of social and material resources increases risk of non-vaccination, we examined here the relationship between deprivation, uptake, and timeliness for four routine childhood vaccines and identified trends over the past decade. METHODS: This retrospective cohort study analysed immunisation data from the Scottish Immunisation Recall System (SIRS) for four routine childhood vaccines in the UK: the third dose of the primary vaccine (TPV), both doses of measles, mumps, rubella (MMR 1 and MMR 2), and the preschool booster (PSB). Immunisations (N = 329,897) were administered between 2008 and 2018. Deprivation was measured via the Scottish Index of Multiple Deprivation (SIMD), ranking postcodes by deprivation decile. Chi-squared tests and cox proportional hazards models assessed the relationship between uptake, timeliness, and deprivation. RESULTS: There is strong evidence for an association between deprivation, uptake, and timeliness. Uptake for all childhood immunisations are very high, especially for TPV and MMR 1 (>98.0%), though certain deprivation deciles exhibit increased risks of non-vaccination for all vaccines. Delay was pronounced for the 40% most deprived population and for immunisations scheduled at later ages. Absolute PSB and MMR 2 uptake has improved since 2008; however, disparities in uptake have increased for all vaccines since the 2006 birth cohort. CONCLUSION: Both timeliness and uptake are strongly associated with deprivation. While absolute uptake was high for all vaccines, relative uptake and timeliness has been worsening for most groups; the reason for this decline is unclear. Here we identified subgroups that may require targeted interventions to facilitate uptake and timeliness for essential childhood vaccines.


Asunto(s)
Disparidades en Atención de Salud , Cobertura de Vacunación/estadística & datos numéricos , Factores de Edad , Niño , Preescolar , Femenino , Humanos , Programas de Inmunización , Esquemas de Inmunización , Inmunización Secundaria , Masculino , Evaluación de Resultado en la Atención de Salud , Modelos de Riesgos Proporcionales , Vigilancia en Salud Pública , Estudios Retrospectivos , Escocia/epidemiología , Vacunación
5.
Arch Dis Child ; 102(4): 323-327, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27806968

RESUMEN

OBJECTIVE: Rotavirus (RV) vaccination was introduced into the UK vaccination schedule in July 2013. This retrospective observational study assessed, in a UK setting, the impact of the vaccination programme on the number of RV gastroenteritis (RVGE) admissions, the complications of RVGE in hospitalised children, and the impact on hospital-acquired RVGE. DESIGN: Over a 3 year period, 1-year before and 2 years after the introduction of the vaccine, children under 13 years of age in Lothian region with RV+ve stool sample by PCR were identified, retrospectively, and admission data (length of stay, complications) and vaccination status analysed. Viral strain (vaccine/wild type) was typed using PCR-based methods in vaccinated children. RESULTS: Vaccination uptake in the first 2 years of the programme was 93-94%. In the 2 years following vaccine introduction, the annual number of confirmed RVGE admissions fell by 84.7% (95% CI 75.4 to 91.0), from 131 to 20, bed days reduced by 91.1% (86.9 to 94.1), from 325 to 29, and suspected hospital-acquired infections reduced by 95.7% (73.5-99.5), from 23 to 1. The reduction in admissions was seen across all age groups despite the vaccination only being administered to infants. Despite the reduction in incidence, complication rates in children admitted with RVGE remained unchanged across the three study years. A frequent incidental finding was RV vaccine strain in the stools of vaccinated children, up to 43 days after last immunisation. There has been no concurrent increase in rate of intussusception in the region. CONCLUSIONS: These results provide encouraging initial evidence of the public health benefit, including to the unimmunised population, of the RV vaccination programme in the UK.


Asunto(s)
Infecciones por Rotavirus/prevención & control , Vacunas contra Rotavirus , Preescolar , Infección Hospitalaria/prevención & control , Heces/virología , Gastroenteritis/prevención & control , Hospitalización/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Intususcepción/prevención & control , Tiempo de Internación/estadística & datos numéricos , Estudios Retrospectivos , Rotavirus/aislamiento & purificación , Escocia , Vacunación/estadística & datos numéricos
6.
BMC Infect Dis ; 16: 390, 2016 08 09.
Artículo en Inglés | MEDLINE | ID: mdl-27506837

RESUMEN

BACKGROUND: Scotland introduced PCV7 and PCV13 immunisation in young children in 2006 and 2010 respectively. One recent study from the United States reported a decrease in hospitalisation rates for all-cause pneumonia most notably in adults older than 75 years of age following PCV7 introduction in the US child population. We aimed to examine the effect of PCV7 and PCV13 on hospitalisation rates for all-cause pneumonia across all age groups in Scotland. METHODS: We linked hospital records and death certification datasets for the entire Scottish population for the period 2000 to 2012. We included all cases where the primary / secondary diagnosis was pneumonia. Differences in hospital admission rates for pneumonia by age group were calculated using the difference in average annual rates for each period. RESULTS: We estimated that all-cause pneumonia hospitalisation rates in children <2 years decreased by about 30 % in the post-PCV-13 period compared with the pre-PCV period. However, in adults aged 75-84 years and ≥85 years, all-cause pneumonia hospitalisation rates increased by 63 and 46 % respectively in the post-PCV 13 period compared to the pre-PCV period. This resulted in an additional 7000 hospitalisations across all age groups in Scotland in 2012 about half of which were in adults >75 years. At the same time, the median length of hospital stay decreased by a third in children <2 years and by about 20 % in adults >75 years in the post-PCV13 period compared to the pre-PCV period. Additionally, there was an 11 % reduction in deaths due to all-cause pneumonia, and 30 % reduction in pneumococcal hospitalisations across all age groups in the post-PCV13 period compared with pre-PCV period. DISCUSSION: The modest and sustained decline in the rates of hospitalisation for all-cause pneumonia in children and the reduction in proportion of pneumonia hospitalisations in children coded as pneumococcal disease in the post-PCV period should alleviate concerns that pneumococcal serotype replacement may have resulted in an increased pneumonia burden in this age group. The indirect impact of child PCV immunisation in those not vaccinated (in terms of reduction in all-cause pneumonia hospitalisations in the elderly) has not been seen in Scotland. Our results are likely to be confounded by changes in clinical coding and healthcare practices over the same period. CONCLUSIONS: Our results illustrate that health care planners cannot, with confidence, predict indirect PCV vaccine impacts on hospitalisations. IPD surveillance across all age groups is needed to assess the indirect effects of PCV in the community.


Asunto(s)
Vacuna Neumocócica Conjugada Heptavalente/uso terapéutico , Infecciones Neumocócicas/epidemiología , Vacunas Neumococicas/uso terapéutico , Neumonía Neumocócica/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Registros de Hospitales , Hospitalización/estadística & datos numéricos , Humanos , Lactante , Tiempo de Internación , Persona de Mediana Edad , Infecciones Neumocócicas/prevención & control , Neumonía/epidemiología , Neumonía Neumocócica/prevención & control , Escocia/epidemiología , Streptococcus pneumoniae/inmunología , Vacunación/estadística & datos numéricos , Adulto Joven
7.
BMC Public Health ; 12: 227, 2012 Mar 22.
Artículo en Inglés | MEDLINE | ID: mdl-22440092

RESUMEN

BACKGROUND: Coronary heart disease and stroke are leading causes of mortality and ill health in Scotland, and clear associations have been found in previous studies between air pollution and cardiovascular disease. This study aimed to use routinely available data to examine whether there is any evidence of an association between short-term exposure to particulate matter (measured as PM10, particles less than 10 micrograms per cubic metre) and hospital admissions due to cardiovascular disease, in the two largest cities in Scotland during the years 2000 to 2006. METHODS: The study utilised an ecological time series design, and the analysis was based on overdispersed Poisson log-linear models. RESULTS: No consistent associations were found between PM10 concentrations and cardiovascular hospital admissions in either of the cities studied, as all of the estimated relative risks were close to one, and all but one of the associated 95% confidence intervals contained the null risk of one. CONCLUSIONS: This study suggests that in small cities, where air quality is relatively good, then either PM10 concentrations have no effect on cardiovascular ill health, or that the routinely available data and the corresponding study design are not sufficient to detect an association.


Asunto(s)
Contaminación del Aire/efectos adversos , Enfermedad Coronaria/epidemiología , Exposición a Riesgos Ambientales/efectos adversos , Hospitalización/estadística & datos numéricos , Material Particulado/análisis , Accidente Cerebrovascular/epidemiología , Salud Urbana/tendencias , Ciudades , Enfermedad Coronaria/terapia , Interpretación Estadística de Datos , Humanos , Modelos Lineales , Proyectos de Investigación , Factores de Riesgo , Escocia/epidemiología , Accidente Cerebrovascular/terapia
8.
Int J Antimicrob Agents ; 30(1): 78-82, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17475448

RESUMEN

We questioned 62 dermatology outpatients with atopic eczema and Staphylococcus aureus colonisation regarding their use of topical preparations containing fusidic acid during the previous 6 months as well as the pattern of any such use. Recent exposure to topical fusidic acid was significantly correlated with the presence of fusidic acid-resistant S. aureus (FRSA) (P=0.04). There was also a significant trend towards increasing FRSA carriage with increased duration of use. Short courses of 2 weeks or less did not appear to change the FRSA profile compared with non-exposure, and intermittent usage appeared to be the most detrimental, although subgroup sizes were small. Our study cautions against prolonged or intermittent use of fusidic acid-containing products in patients with eczema.


Asunto(s)
Dermatitis Atópica/microbiología , Farmacorresistencia Bacteriana , Ácido Fusídico/farmacología , Ácido Fusídico/uso terapéutico , Infecciones Cutáneas Estafilocócicas/microbiología , Staphylococcus aureus/efectos de los fármacos , Administración Tópica , Portador Sano/microbiología , Niño , Preescolar , Dermatitis Atópica/complicaciones , Femenino , Ácido Fusídico/administración & dosificación , Humanos , Lactante , Masculino , Pruebas de Sensibilidad Microbiana , Staphylococcus aureus/aislamiento & purificación
9.
BMC Public Health ; 4: 30, 2004 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-15274745

RESUMEN

BACKGROUND: Meningitis caused by Neisseria meningitidis is a serious infection which is most common in young children and adolescents. This study investigated the relationships between the incidence and age distribution of meningococcal disease, and socioeconomic environment. METHODS: An ecological design was used, including mapping using a Geographical Information System (GIS) at census ward level. RESULTS: Incidence of meningococcal disease was highest in the most deprived wards, with a relative risk of 1.97 (1.55 - 2.51). Mapping revealed geographical coincidence of deprivation and meningococcal disease, particularly in urban areas. Two-thirds of the increased incidence was due to cases in the under fives. CONCLUSIONS: The results suggest that area deprivation is a risk factor for meningococcal disease, and that its effects are seen most in young children.


Asunto(s)
Sistemas de Información Geográfica , Infecciones Meningocócicas/epidemiología , Áreas de Pobreza , Adolescente , Distribución por Edad , Censos , Niño , Preescolar , Análisis por Conglomerados , Inglaterra/epidemiología , Humanos , Incidencia , Lactante , Infecciones Meningocócicas/economía , Infecciones Meningocócicas/microbiología , Neisseria meningitidis/patogenicidad , Distribución de Poisson , Informática en Salud Pública , Factores de Riesgo , Clase Social , Topografía Médica/métodos , Salud Urbana/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA